The first trial date in the legal battle against the Dali's owners is set for June 2026, and that's only for "phase one" of the trial.

Roth MKM analyst Sean McGowan initiated coverage of Synergy CHC (SNYR) with a Buy rating and $10 price target In 2023, the company had ...

“The personal stories of the suspect, victim and their families are decided in the first act and continue during the trial in Act II,” says Kenn Adams, Synergy Theater’s artistic director ...

Atreo, Inc., a next generation Randomization and Trial Supply Management (RTSM) technology company, has announced a strategic preferred partnership with N-SIDE, a global pioneer in clinical trial ...